复方米非司酮片联合米索前列醇片治疗终止10～16周妊娠及稽留流产的临床研究OA北大核心CSCDCSTPCD
Clinical trial of compound mifepristone tablets combined with misoprostol tablets in the treatment of termination pregnancy from 10 to 16 weeks and missed abortion
目的 观察复方米非司酮片联合米索前列醇片治疗终止10～16周妊娠及稽留流产的临床疗效和安全性.方法 将419例自愿终止10 ～ 16周妊娠(269例)以及稽留流产(150例)患者随机分为终止妊娠单方组(A组)95例、终止妊娠复方组(B组)174例、稽留流产单方组(C组)53例、稽留流产复方组(D组)97例.A、C组予以米非司酮50 mg,bid,口服,在第3次服药后的12 h阴道放置0.9％ NaCl湿化的米索前列醇0.6 mg.B、D组予以复方…查看全部>>
Objective To observe the clinical efficacy and safety of compound mifepristone tablets combined with misoprostol tablets in termination pregnancy from 10 to 16 weeks and treatment of missed abortion.Methods A total of 419 patients with pregnancy from 10 to 16 weeks (n=269 cases) and missed abortion (n =150 cases) were randomly divided into group A (termination pregnancy with mifepristone,n =95 cases),group B (termination pregnancy with compound mifepristone,…查看全部>>
王蓓颖;李晓翠;王海云
同济大学附属上海市第一妇婴保健院计划生育科,上海201204同济大学附属上海市第一妇婴保健院计划生育科,上海201204同济大学附属上海市第一妇婴保健院计划生育科,上海201204
医药卫生
复方米非司酮片米非司酮片米索前列醇片终止妊娠稽留流产
compound mifepristonemifepristonemisoprostolpregnancy terminationmissed abortion
《中国临床药理学杂志》 2017 (6)
499-501,517,4
评论